The mean histogram of each index of recycled asphalt. by Ying Fang (147352)

Concentrations of T2AA and cell lines used in previously published literature. by Jessica E. Packard (16641690)

Concentrations of PCNA-I1 and cell lines used in previously published literature. by Jessica E. Packard (16641690)

The effect of BRA dosage on the <i>R</i> value of aged asphalt. by Ying Fang (147352)

Summary of unprocessed and processed aniPOND mass spectrometry data. by Jessica E. Packard (16641690)

Microscopic morphology structure of asphalt samples before and after aging and recycling. by Ying Fang (147352)

DSC test results of recycled asphalt samples. by Ying Fang (147352)

The effect of BRA dosage on the <i>J</i>_<i>nr</i> value of aged asphalt. by Ying Fang (147352)

Performance metrics across clinical specialties and hospitals. by Chao Song (379006)

Experimental setup of the chemotaxis assay. by Yixuan Chen (47490)

Wnt10b suppresses DOX-induced apoptosis in AC16 cells. by Lei Chen (54296)

DOX causes cell toxicity in AC16 cardiomyocyte cells. by Lei Chen (54296)

The p21 ELISA assay was used to assess the effects of MBC-005 on tumor cell expression of p21. by Bryan S. Margulies (21492667)

Diet composition and nutritional values. by Taynara Aparecida Vieira (16401726)

“…After developing cardiac remodeling, the animals were again distributed into three groups to receive BLE (50 mg/kg/day) or placebo (water) via gavage for 10 weeks: C, HSF and HSF + BLE. The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Nutritional and metabolic analysis. by Taynara Aparecida Vieira (16401726)

“…After developing cardiac remodeling, the animals were again distributed into three groups to receive BLE (50 mg/kg/day) or placebo (water) via gavage for 10 weeks: C, HSF and HSF + BLE. The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Cardiovascular parameters. by Taynara Aparecida Vieira (16401726)

“…After developing cardiac remodeling, the animals were again distributed into three groups to receive BLE (50 mg/kg/day) or placebo (water) via gavage for 10 weeks: C, HSF and HSF + BLE. The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Wnt10b attenuated DOX-induced damage through mitochondrial modification. by Lei Chen (54296)

Fig 9 - by Rashida Nayeem (11851764)

Wnt10b fine modulation of MAPK signaling in AC16 cells. by Lei Chen (54296)

Workflow of the IRSP with the intervention path highlighted. by Chao Song (379006)